The demand for overactive bladder therapeutics is increasing due to the rising prevalence of OAB worldwide. According to the International Continence Society, overactive bladder affects up to 16% of adults over the age of 18. The condition is more common in women than men and increases in prevalence with age. In addition, lifestyle factors such as obesity, smoking, and caffeine intake can contribute to the development of OAB. The global overactive bladder therapeutics market is expected to grow in the coming years, driven by the increasing prevalence of OAB and the demand for effective treatments.

The Overactive Bladder Therapeutics Market is expected to reach $5.5 billion by 2025, growing at a compound annual growth rate (CAGR) of 2.5% from 2018 to 2025. The demand for OAB therapeutics is also driven by the impact of the condition on quality of life. OAB can significantly impact a person's ability to participate in daily activities and can lead to social isolation and mental health issues. Therefore, there is a strong demand for effective treatments that can improve symptoms and restore quality of life.

Read more @ https://influentialblogging.blogspot.com/2023/04/global-overactive-bladder-therapeutics.html